<Record>
<Term>Ferumoxtran-10</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Contrast Agent</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Biomedical Material/Reagent/Image Enhancement Agent/Contrast Agent/Ferumoxtran-10</ClassificationPath>
<BroaderTerm>Contrast Agent</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Reagent</BroaderTerm>
<BroaderTerm>Image Enhancement Agent</BroaderTerm>
<BroaderTerm>Ferumoxtran-10</BroaderTerm>
<BroaderTerm>Biomedical Material</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>Combidex</Synonym>
<Synonym>Ferumoxtran-10</Synonym>
<Synonym>USPIO</Synonym>
<Synonym>Ultrasmall Particulate Iron Oxide</Synonym>
<Description>A synthetic ultrasmall superparamagnetic iron oxide composed of dextran-coated iron oxide nanoparticles (also known as 'ultrasmall particulate iron oxides' or USPIO). Ferumoxtran-10, which accumulates in non-cancerous lymphatic tissue, is used as a molecular resonance imaging (MRI) contrast agent. (NCI04)</Description>
<Source>NCI Thesaurus</Source>
</Record>
